Hørslev-Petersen K, Bentsen K D, Engström-Laurent A, Junker P, Halberg P, Lorenzen I
Department of Medicine, University of Copenhagen, Hvidovre Hospital, Denmark.
Ann Rheum Dis. 1988 Feb;47(2):116-26. doi: 10.1136/ard.47.2.116.
Increased serum levels of the amino terminal type III procollagen peptide and serum hyaluronan were demonstrated in patients with rheumatoid arthritis. In patients with active disease a significant correlation was shown between serum levels of the propeptide and hyaluronan and the clinical signs of synovitis reflecting the extent of synovial inflammation. During recovery the serum propeptide and serum hyaluronan showed a delayed decline as compared with the clinical signs of synovitis and the acute phase protein response. This probably reflects the presence of persistent subclinical chronic inflammation. Normal serum propeptide levels in rheumatoid arthritis were associated with a good prognosis without progression of erosive joint lesions. Azathioprine reduced the number of patients with progression of erosive joint lesions and caused a more marked suppression of the serum propeptide than levamisole and penicillamine.
类风湿关节炎患者血清Ⅲ型前胶原氨基端肽和血清透明质酸水平升高。在活动期疾病患者中,前肽和透明质酸的血清水平与反映滑膜炎程度的滑膜炎临床体征之间存在显著相关性。在恢复过程中,与滑膜炎临床体征和急性期蛋白反应相比,血清前肽和血清透明质酸水平下降延迟。这可能反映了持续性亚临床慢性炎症的存在。类风湿关节炎患者血清前肽水平正常与无侵蚀性关节病变进展的良好预后相关。硫唑嘌呤减少了侵蚀性关节病变进展的患者数量,并且比左旋咪唑和青霉胺更显著地抑制血清前肽。